Global Biolayer Interferometry (BLI) Supply, Demand and Key Producers, 2024-2030

Description

Biolayer Interferometry (BLI) is a label-free optical technique for measuring biomolecular interactions in real-time. It analyzes the interference pattern of white light reflected from an immobilized protein layer on the biosensor tip and an internal reference layer. Only molecules binding to or dissociating from the biosensor can shift the interference pattern, making BLI unique and ideal for protein binding, quantitation, affinity, and kinetics in crude samples. Bio-Layer Interferometry measures biomolecular interactions by analyzing interference patterns of white light reflected from the surface of a biosensor tip. In BLI experiment, one molecule is immobilized to a biosensor and binding to a second molecule is measured. The molecules that bind or dissociate themselves from the biosensor causes a shift in the interference pattern that is measured in real-time. The unbound molecules, variations in the refractive index of the surrounding medium or flow rate, however, do not affect the interference. This unique feature of BLI technology therefore allows measuring crude samples to determine the kinetics and affinity of molecular interactions. Anotheradvantage of BLI is that the number of sensors can be scaled up easily without making the system more error-prone or complex. Theoretically, there is no need to regenerate single sensors, because immobilizing an equal amount of ligand on additional sensors can easily create duplicates of the surface.

The global Biolayer Interferometry (BLI) market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

This report studies the global Biolayer Interferometry (BLI) demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Biolayer Interferometry (BLI), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biolayer Interferometry (BLI) that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Biolayer Interferometry (BLI) total market, 2019-2030, (USD Million)
Global Biolayer Interferometry (BLI) total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Biolayer Interferometry (BLI) total market, key domestic companies, and share, (USD Million)
Global Biolayer Interferometry (BLI) revenue by player, revenue and market share 2019-2024, (USD Million)
Global Biolayer Interferometry (BLI) total market by Type, CAGR, 2019-2030, (USD Million)
Global Biolayer Interferometry (BLI) total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Biolayer Interferometry (BLI) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ichor Life Sciences, Inc, Creative BioMart, GenScript, ROCKLAND IMMUNOCHEMICALS, INC, BPS Bioscience, Inc, Creative Proteomics, Creative Biostructure, Profacgen, Creative Biolabs, Biocult, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Biolayer Interferometry (BLI) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Biolayer Interferometry (BLI) Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Biolayer Interferometry (BLI) Market, Segmentation by Type
    Affinity and Kinetic Analysis
    Drug and Antibody Screening
    Drug and Antibody Discovery
    Protein Quantification
    Others

Global Biolayer Interferometry (BLI) Market, Segmentation by Application:
    Pharmaceutical Industry
    Diagnostics
    Biotechnology
    Scientific Research
    Others

Companies Profiled:
    Ichor Life Sciences, Inc
    Creative BioMart
    GenScript
    ROCKLAND IMMUNOCHEMICALS, INC
    BPS Bioscience, Inc
    Creative Proteomics
    Creative Biostructure
    Profacgen
    Creative Biolabs
    Biocult
    KMD Bioscience Co., Ltd

Key Questions Answered
1. How big is the global Biolayer Interferometry (BLI) market?
2. What is the demand of the global Biolayer Interferometry (BLI) market?
3. What is the year over year growth of the global Biolayer Interferometry (BLI) market?
4. What is the total value of the global Biolayer Interferometry (BLI) market?
5. Who are the Major Players in the global Biolayer Interferometry (BLI) market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Biolayer Interferometry (BLI) Introduction
    1.2 World Biolayer Interferometry (BLI) Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Biolayer Interferometry (BLI) Total Market by Region (by Headquarter Location)
        1.3.1 World Biolayer Interferometry (BLI) Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company Biolayer Interferometry (BLI) Revenue (2019-2030)
        1.3.3 China Based Company Biolayer Interferometry (BLI) Revenue (2019-2030)
        1.3.4 Europe Based Company Biolayer Interferometry (BLI) Revenue (2019-2030)
        1.3.5 Japan Based Company Biolayer Interferometry (BLI) Revenue (2019-2030)
        1.3.6 South Korea Based Company Biolayer Interferometry (BLI) Revenue (2019-2030)
        1.3.7 ASEAN Based Company Biolayer Interferometry (BLI) Revenue (2019-2030)
        1.3.8 India Based Company Biolayer Interferometry (BLI) Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Biolayer Interferometry (BLI) Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World Biolayer Interferometry (BLI) Consumption Value (2019-2030)
    2.2 World Biolayer Interferometry (BLI) Consumption Value by Region
        2.2.1 World Biolayer Interferometry (BLI) Consumption Value by Region (2019-2024)
        2.2.2 World Biolayer Interferometry (BLI) Consumption Value Forecast by Region (2025-2030)
    2.3 United States Biolayer Interferometry (BLI) Consumption Value (2019-2030)
    2.4 China Biolayer Interferometry (BLI) Consumption Value (2019-2030)
    2.5 Europe Biolayer Interferometry (BLI) Consumption Value (2019-2030)
    2.6 Japan Biolayer Interferometry (BLI) Consumption Value (2019-2030)
    2.7 South Korea Biolayer Interferometry (BLI) Consumption Value (2019-2030)
    2.8 ASEAN Biolayer Interferometry (BLI) Consumption Value (2019-2030)
    2.9 India Biolayer Interferometry (BLI) Consumption Value (2019-2030)

3 World Biolayer Interferometry (BLI) Companies Competitive Analysis
    3.1 World Biolayer Interferometry (BLI) Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Biolayer Interferometry (BLI) Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Biolayer Interferometry (BLI) in 2023
        3.2.3 Global Concentration Ratios (CR8) for Biolayer Interferometry (BLI) in 2023
    3.3 Biolayer Interferometry (BLI) Company Evaluation Quadrant
    3.4 Biolayer Interferometry (BLI) Market: Overall Company Footprint Analysis
        3.4.1 Biolayer Interferometry (BLI) Market: Region Footprint
        3.4.2 Biolayer Interferometry (BLI) Market: Company Product Type Footprint
        3.4.3 Biolayer Interferometry (BLI) Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: Biolayer Interferometry (BLI) Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Biolayer Interferometry (BLI) Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Biolayer Interferometry (BLI) Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Biolayer Interferometry (BLI) Consumption Value Comparison
        4.2.1 United States VS China: Biolayer Interferometry (BLI) Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Biolayer Interferometry (BLI) Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Biolayer Interferometry (BLI) Companies and Market Share, 2019-2024
        4.3.1 United States Based Biolayer Interferometry (BLI) Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Biolayer Interferometry (BLI) Revenue, (2019-2024)
    4.4 China Based Companies Biolayer Interferometry (BLI) Revenue and Market Share, 2019-2024
        4.4.1 China Based Biolayer Interferometry (BLI) Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Biolayer Interferometry (BLI) Revenue, (2019-2024)
    4.5 Rest of World Based Biolayer Interferometry (BLI) Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Biolayer Interferometry (BLI) Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies Biolayer Interferometry (BLI) Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World Biolayer Interferometry (BLI) Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Affinity and Kinetic Analysis
        5.2.2 Drug and Antibody Screening
        5.2.3 Drug and Antibody Discovery
        5.2.4 Protein Quantification
        5.2.5 Others
    5.3 Market Segment by Type
        5.3.1 World Biolayer Interferometry (BLI) Market Size by Type (2019-2024)
        5.3.2 World Biolayer Interferometry (BLI) Market Size by Type (2025-2030)
        5.3.3 World Biolayer Interferometry (BLI) Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
    6.1 World Biolayer Interferometry (BLI) Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Pharmaceutical Industry
        6.2.2 Diagnostics
        6.2.3 Biotechnology
        6.2.4 Scientific Research
        6.2.5 Others
    6.3 Market Segment by Application
        6.3.1 World Biolayer Interferometry (BLI) Market Size by Application (2019-2024)
        6.3.2 World Biolayer Interferometry (BLI) Market Size by Application (2025-2030)
        6.3.3 World Biolayer Interferometry (BLI) Market Size Market Share by Application (2019-2030)

7 Company Profiles
    7.1 Ichor Life Sciences, Inc
        7.1.1 Ichor Life Sciences, Inc Details
        7.1.2 Ichor Life Sciences, Inc Major Business
        7.1.3 Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Product and Services
        7.1.4 Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Ichor Life Sciences, Inc Recent Developments/Updates
        7.1.6 Ichor Life Sciences, Inc Competitive Strengths & Weaknesses
    7.2 Creative BioMart
        7.2.1 Creative BioMart Details
        7.2.2 Creative BioMart Major Business
        7.2.3 Creative BioMart Biolayer Interferometry (BLI) Product and Services
        7.2.4 Creative BioMart Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Creative BioMart Recent Developments/Updates
        7.2.6 Creative BioMart Competitive Strengths & Weaknesses
    7.3 GenScript
        7.3.1 GenScript Details
        7.3.2 GenScript Major Business
        7.3.3 GenScript Biolayer Interferometry (BLI) Product and Services
        7.3.4 GenScript Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 GenScript Recent Developments/Updates
        7.3.6 GenScript Competitive Strengths & Weaknesses
    7.4 ROCKLAND IMMUNOCHEMICALS, INC
        7.4.1 ROCKLAND IMMUNOCHEMICALS, INC Details
        7.4.2 ROCKLAND IMMUNOCHEMICALS, INC Major Business
        7.4.3 ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Product and Services
        7.4.4 ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 ROCKLAND IMMUNOCHEMICALS, INC Recent Developments/Updates
        7.4.6 ROCKLAND IMMUNOCHEMICALS, INC Competitive Strengths & Weaknesses
    7.5 BPS Bioscience, Inc
        7.5.1 BPS Bioscience, Inc Details
        7.5.2 BPS Bioscience, Inc Major Business
        7.5.3 BPS Bioscience, Inc Biolayer Interferometry (BLI) Product and Services
        7.5.4 BPS Bioscience, Inc Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 BPS Bioscience, Inc Recent Developments/Updates
        7.5.6 BPS Bioscience, Inc Competitive Strengths & Weaknesses
    7.6 Creative Proteomics
        7.6.1 Creative Proteomics Details
        7.6.2 Creative Proteomics Major Business
        7.6.3 Creative Proteomics Biolayer Interferometry (BLI) Product and Services
        7.6.4 Creative Proteomics Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Creative Proteomics Recent Developments/Updates
        7.6.6 Creative Proteomics Competitive Strengths & Weaknesses
    7.7 Creative Biostructure
        7.7.1 Creative Biostructure Details
        7.7.2 Creative Biostructure Major Business
        7.7.3 Creative Biostructure Biolayer Interferometry (BLI) Product and Services
        7.7.4 Creative Biostructure Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Creative Biostructure Recent Developments/Updates
        7.7.6 Creative Biostructure Competitive Strengths & Weaknesses
    7.8 Profacgen
        7.8.1 Profacgen Details
        7.8.2 Profacgen Major Business
        7.8.3 Profacgen Biolayer Interferometry (BLI) Product and Services
        7.8.4 Profacgen Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Profacgen Recent Developments/Updates
        7.8.6 Profacgen Competitive Strengths & Weaknesses
    7.9 Creative Biolabs
        7.9.1 Creative Biolabs Details
        7.9.2 Creative Biolabs Major Business
        7.9.3 Creative Biolabs Biolayer Interferometry (BLI) Product and Services
        7.9.4 Creative Biolabs Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Creative Biolabs Recent Developments/Updates
        7.9.6 Creative Biolabs Competitive Strengths & Weaknesses
    7.10 Biocult
        7.10.1 Biocult Details
        7.10.2 Biocult Major Business
        7.10.3 Biocult Biolayer Interferometry (BLI) Product and Services
        7.10.4 Biocult Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Biocult Recent Developments/Updates
        7.10.6 Biocult Competitive Strengths & Weaknesses
    7.11 KMD Bioscience Co., Ltd
        7.11.1 KMD Bioscience Co., Ltd Details
        7.11.2 KMD Bioscience Co., Ltd Major Business
        7.11.3 KMD Bioscience Co., Ltd Biolayer Interferometry (BLI) Product and Services
        7.11.4 KMD Bioscience Co., Ltd Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 KMD Bioscience Co., Ltd Recent Developments/Updates
        7.11.6 KMD Bioscience Co., Ltd Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Biolayer Interferometry (BLI) Industry Chain
    8.2 Biolayer Interferometry (BLI) Upstream Analysis
    8.3 Biolayer Interferometry (BLI) Midstream Analysis
    8.4 Biolayer Interferometry (BLI) Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Biolayer Interferometry (BLI) Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World Biolayer Interferometry (BLI) Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World Biolayer Interferometry (BLI) Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World Biolayer Interferometry (BLI) Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World Biolayer Interferometry (BLI) Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World Biolayer Interferometry (BLI) Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World Biolayer Interferometry (BLI) Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World Biolayer Interferometry (BLI) Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World Biolayer Interferometry (BLI) Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key Biolayer Interferometry (BLI) Players in 2023
 Table 12. World Biolayer Interferometry (BLI) Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global Biolayer Interferometry (BLI) Company Evaluation Quadrant
 Table 14. Head Office of Key Biolayer Interferometry (BLI) Players
 Table 15. Biolayer Interferometry (BLI) Market: Company Product Type Footprint
 Table 16. Biolayer Interferometry (BLI) Market: Company Product Application Footprint
 Table 17. Biolayer Interferometry (BLI) Mergers & Acquisitions Activity
 Table 18. United States VS China Biolayer Interferometry (BLI) Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China Biolayer Interferometry (BLI) Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based Biolayer Interferometry (BLI) Companies, Headquarters (States, Country)
 Table 21. United States Based Companies Biolayer Interferometry (BLI) Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies Biolayer Interferometry (BLI) Revenue Market Share (2019-2024)
 Table 23. China Based Biolayer Interferometry (BLI) Companies, Headquarters (Province, Country)
 Table 24. China Based Companies Biolayer Interferometry (BLI) Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies Biolayer Interferometry (BLI) Revenue Market Share (2019-2024)
 Table 26. Rest of World Based Biolayer Interferometry (BLI) Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies Biolayer Interferometry (BLI) Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies Biolayer Interferometry (BLI) Revenue Market Share (2019-2024)
 Table 29. World Biolayer Interferometry (BLI) Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World Biolayer Interferometry (BLI) Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World Biolayer Interferometry (BLI) Market Size by Type (2025-2030) & (USD Million)
 Table 32. World Biolayer Interferometry (BLI) Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Table 33. World Biolayer Interferometry (BLI) Market Size by Application (2019-2024) & (USD Million)
 Table 34. World Biolayer Interferometry (BLI) Market Size by Application (2025-2030) & (USD Million)
 Table 35. Ichor Life Sciences, Inc Basic Information, Manufacturing Base and Competitors
 Table 36. Ichor Life Sciences, Inc Major Business
 Table 37. Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Product and Services
 Table 38. Ichor Life Sciences, Inc Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. Ichor Life Sciences, Inc Recent Developments/Updates
 Table 40. Ichor Life Sciences, Inc Competitive Strengths & Weaknesses
 Table 41. Creative BioMart Basic Information, Manufacturing Base and Competitors
 Table 42. Creative BioMart Major Business
 Table 43. Creative BioMart Biolayer Interferometry (BLI) Product and Services
 Table 44. Creative BioMart Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. Creative BioMart Recent Developments/Updates
 Table 46. Creative BioMart Competitive Strengths & Weaknesses
 Table 47. GenScript Basic Information, Manufacturing Base and Competitors
 Table 48. GenScript Major Business
 Table 49. GenScript Biolayer Interferometry (BLI) Product and Services
 Table 50. GenScript Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. GenScript Recent Developments/Updates
 Table 52. GenScript Competitive Strengths & Weaknesses
 Table 53. ROCKLAND IMMUNOCHEMICALS, INC Basic Information, Manufacturing Base and Competitors
 Table 54. ROCKLAND IMMUNOCHEMICALS, INC Major Business
 Table 55. ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Product and Services
 Table 56. ROCKLAND IMMUNOCHEMICALS, INC Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. ROCKLAND IMMUNOCHEMICALS, INC Recent Developments/Updates
 Table 58. ROCKLAND IMMUNOCHEMICALS, INC Competitive Strengths & Weaknesses
 Table 59. BPS Bioscience, Inc Basic Information, Manufacturing Base and Competitors
 Table 60. BPS Bioscience, Inc Major Business
 Table 61. BPS Bioscience, Inc Biolayer Interferometry (BLI) Product and Services
 Table 62. BPS Bioscience, Inc Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. BPS Bioscience, Inc Recent Developments/Updates
 Table 64. BPS Bioscience, Inc Competitive Strengths & Weaknesses
 Table 65. Creative Proteomics Basic Information, Manufacturing Base and Competitors
 Table 66. Creative Proteomics Major Business
 Table 67. Creative Proteomics Biolayer Interferometry (BLI) Product and Services
 Table 68. Creative Proteomics Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 69. Creative Proteomics Recent Developments/Updates
 Table 70. Creative Proteomics Competitive Strengths & Weaknesses
 Table 71. Creative Biostructure Basic Information, Manufacturing Base and Competitors
 Table 72. Creative Biostructure Major Business
 Table 73. Creative Biostructure Biolayer Interferometry (BLI) Product and Services
 Table 74. Creative Biostructure Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 75. Creative Biostructure Recent Developments/Updates
 Table 76. Creative Biostructure Competitive Strengths & Weaknesses
 Table 77. Profacgen Basic Information, Manufacturing Base and Competitors
 Table 78. Profacgen Major Business
 Table 79. Profacgen Biolayer Interferometry (BLI) Product and Services
 Table 80. Profacgen Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 81. Profacgen Recent Developments/Updates
 Table 82. Profacgen Competitive Strengths & Weaknesses
 Table 83. Creative Biolabs Basic Information, Manufacturing Base and Competitors
 Table 84. Creative Biolabs Major Business
 Table 85. Creative Biolabs Biolayer Interferometry (BLI) Product and Services
 Table 86. Creative Biolabs Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 87. Creative Biolabs Recent Developments/Updates
 Table 88. Creative Biolabs Competitive Strengths & Weaknesses
 Table 89. Biocult Basic Information, Manufacturing Base and Competitors
 Table 90. Biocult Major Business
 Table 91. Biocult Biolayer Interferometry (BLI) Product and Services
 Table 92. Biocult Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 93. Biocult Recent Developments/Updates
 Table 94. Biocult Competitive Strengths & Weaknesses
 Table 95. KMD Bioscience Co., Ltd Basic Information, Manufacturing Base and Competitors
 Table 96. KMD Bioscience Co., Ltd Major Business
 Table 97. KMD Bioscience Co., Ltd Biolayer Interferometry (BLI) Product and Services
 Table 98. KMD Bioscience Co., Ltd Biolayer Interferometry (BLI) Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 99. KMD Bioscience Co., Ltd Recent Developments/Updates
 Table 100. KMD Bioscience Co., Ltd Competitive Strengths & Weaknesses
 Table 101. Global Key Players of Biolayer Interferometry (BLI) Upstream (Raw Materials)
 Table 102. Global Biolayer Interferometry (BLI) Typical Customers


List of Figures
 Figure 1. Biolayer Interferometry (BLI) Picture
 Figure 2. World Biolayer Interferometry (BLI) Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Biolayer Interferometry (BLI) Total Revenue (2019-2030) & (USD Million)
 Figure 4. World Biolayer Interferometry (BLI) Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World Biolayer Interferometry (BLI) Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company Biolayer Interferometry (BLI) Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company Biolayer Interferometry (BLI) Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company Biolayer Interferometry (BLI) Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company Biolayer Interferometry (BLI) Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company Biolayer Interferometry (BLI) Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company Biolayer Interferometry (BLI) Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company Biolayer Interferometry (BLI) Revenue (2019-2030) & (USD Million)
 Figure 13. Biolayer Interferometry (BLI) Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World Biolayer Interferometry (BLI) Consumption Value (2019-2030) & (USD Million)
 Figure 16. World Biolayer Interferometry (BLI) Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States Biolayer Interferometry (BLI) Consumption Value (2019-2030) & (USD Million)
 Figure 18. China Biolayer Interferometry (BLI) Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe Biolayer Interferometry (BLI) Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan Biolayer Interferometry (BLI) Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea Biolayer Interferometry (BLI) Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN Biolayer Interferometry (BLI) Consumption Value (2019-2030) & (USD Million)
 Figure 23. India Biolayer Interferometry (BLI) Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of Biolayer Interferometry (BLI) by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for Biolayer Interferometry (BLI) Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for Biolayer Interferometry (BLI) Markets in 2023
 Figure 27. United States VS China: Biolayer Interferometry (BLI) Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Biolayer Interferometry (BLI) Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World Biolayer Interferometry (BLI) Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World Biolayer Interferometry (BLI) Market Size Market Share by Type in 2023
 Figure 31. Affinity and Kinetic Analysis
 Figure 32. Drug and Antibody Screening
 Figure 33. Drug and Antibody Discovery
 Figure 34. Protein Quantification
 Figure 35. Others
 Figure 36. World Biolayer Interferometry (BLI) Market Size Market Share by Type (2019-2030)
 Figure 37. World Biolayer Interferometry (BLI) Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Figure 38. World Biolayer Interferometry (BLI) Market Size Market Share by Application in 2023
 Figure 39. Pharmaceutical Industry
 Figure 40. Diagnostics
 Figure 41. Biotechnology
 Figure 42. Scientific Research
 Figure 43. Others
 Figure 44. World Biolayer Interferometry (BLI) Market Size Market Share by Application (2019-2030)
 Figure 45. Biolayer Interferometry (BLI) Industrial Chain
 Figure 46. Methodology
 Figure 47. Research Process and Data Source

Companies Mentioned

Ichor Life Sciences, Inc
Creative BioMart
GenScript
ROCKLAND IMMUNOCHEMICALS, INC
BPS Bioscience, Inc
Creative Proteomics
Creative Biostructure
Profacgen
Creative Biolabs
Biocult
KMD Bioscience Co., Ltd